Start for free
Start for free
EC

Euclidean Capital

North America, New York, United States, New York

Description

Euclidean Capital is an investment firm that invests in individual and family services management.

Investor Profile

Euclidean Capital has made 50 investments, with 8 in the past 12 months and 8% as lead.

Stage Focus

  • Series A (26%)
  • Series B (24%)
  • Series C (20%)
  • Series Unknown (14%)
  • Series E (8%)
  • Series D (4%)
  • Series F (2%)
  • Seed (2%)

Country Focus

  • United States (96%)
  • Sweden (2%)
  • India (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Artificial Intelligence (Ai)
  • Medical Device
  • Genetics
  • Life Science
  • Financial Services
  • Fintech
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Euclidean Capital frequently co-invest with?

Team8
Team8
Asia, Tel Aviv, Israel, Tel Aviv-yafo
Co-Investments: 5
Nextech Invest
Nextech Invest
Europe, Zurich, Switzerland, Zürich
Co-Investments: 4
Alexandria Venture Investments
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 7
Google Ventures
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 4
Casdin Capital
Casdin Capital
North America, New York, United States, New York
Co-Investments: 5
OUP (Osage University Partners)
OUP (Osage University Partners)
North America, Pennsylvania, United States, Bala Cynwyd
Co-Investments: 6
Polaris Partners
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 5
The Column Group
The Column Group
North America, California, United States, San Francisco
Co-Investments: 17
Illumina Ventures
Illumina Ventures
North America, California, United States, Foster City
Co-Investments: 4
Lux Capital
Lux Capital
North America, New York, United States, New York
Co-Investments: 4

Which angels does Euclidean Capital often collaborate with?

TW
Tom Williams
North America, California, United States, San Francisco
Shared Deals: 1
JD
John Doerr
North America, California, United States, Menlo Park
Shared Deals: 2
Shai Wininger
Shai Wininger
Asia, Israel
Shared Deals: 1
JC
John Chambers
North America, California, United States, San Jose
Shared Deals: 2
JT
Joe Tucci
North America, Illinois, United States, Chicago
Shared Deals: 1
BG
Bill Gates
North America, Washington, United States, Seattle
Shared Deals: 3
Dave Strohm
Dave Strohm
North America, California, United States, San Francisco
Shared Deals: 1
LP
Lowell Putnam
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by Euclidean Capital?

Neurona Therapeutics

San Francisco, California, United States

Neurona Therapeutics develops cell therapies for neurological disorders, focusing on treatments like NRTX-1001 for epilepsy.

BiotechnologyHealth CareTherapeutics
Series FApr 3, 2025
Amount Raised: $102,000,000
Zeitview

Los Angeles, California, United States

Zeitview is an aerial data analytics platform that provides aerial drone services for energy and infrastructure sectors.

Artificial Intelligence (AI)ConstructionDronesMapping Services
Series UnknownMar 5, 2025
Amount Raised: $60,000,000
Leal Therapeutics

Worcester, Massachusetts, United States

Leal Therapeutics develops novel therapeutics for patients.

MedicalTherapeutics
Series UnknownOct 30, 2024
Amount Raised: $6,000,000
Judo Bio

Cambridge, Massachusetts, United States

Judo Bio is a biotechnology company that develops precision therapeutics targeting specific cell populations to address genetic diseases.

BiotechnologyLife ScienceMedicalTherapeutics
Series AOct 7, 2024
Amount Raised: $75,000,000
Nura Bio

South San Francisco, California, United States

Nura Bio is a clinical-stage biopharmaceutical company focused on developing neuroprotective therapies to treat neurological diseases.

BiotechnologyHealth CareMedicalWellness
Series ASep 17, 2024
Amount Raised: $68,000,000
Circle Pharma

San Francisco, California, United States

Circle Pharma is a biotechnology company creating bioavailable macrocyclic peptide therapeutics that target protein-protein interactions.

BiotechnologyClinical TrialsHealth CareTherapeutics
Series DSep 3, 2024
Amount Raised: $90,000,000
Neo Asset Management

Mumbai, Maharashtra, India

Neo Asset Management offers portfolio management, investment advisory services, and asset allocation strategies to their clients.

Asset ManagementConsultingFinanceFinancial Services
Series UnknownAug 12, 2024
Amount Raised: $47,642,582
GrayMatter Robotics

Gardena, California, United States

GrayMatter Robotics provides AI-powered robotic solutions that enhance productivity and efficiency for high-mix manufacturers.

Artificial Intelligence (AI)Machine LearningRobotics
Series BJun 20, 2024
Amount Raised: $45,000,000
InduPro

Seattle, Washington, United States

InduPro is a biotechnology company that specializes in protein therapeutics and cell-surface platform technologies.

BiotechnologyMedicalTherapeutics
Series AJun 13, 2024
Amount Raised: $85,000,000
FundGuard

New York, New York, United States

FundGuard is an artificial intelligence-powered and cloud native investment accounting operating system.

Artificial Intelligence (AI)FinanceFinancial ServicesFinTech
Series CMar 25, 2024
Amount Raised: $100,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsNewsletterPricing

Free tools

Pre-Money and Post-Money Valuation Calculator